Renal Cell Carcinoma Marker (gp200) Ab-1 Mouse Monoclonal Antibody, Epredia™
Provide accurate, reproducible results with the Epredia™ Renal Cell Carcinoma Marker (gp200) Ab-1, Mouse Monoclonal Antibody.
Manufacturer: Epredia MS409R7
DescriptionIn normal kidney, gp200 is localized along the brush border of the pars convoluta and pars recta segments of the proximal tubule, as well as focally along the luminal surface of Bowman's capsule adjoining the outgoing proximal tubule. Of other normal tissues examined, the gp200 is also localized along the luminal surfaces of breast lobules and ducts, the luminal surface of the epididymal tubular epithelium, within the cytoplasm of parathyroid parenchymal cells, and focally within the colloid of thyroid follicles. Thirty-one other normal tissues do not express similar or cross-reacting antigens. Reportedly, gp200 is expressed by 93% of primary and 84% of metastatic renal cell carcinomas.
Host Species: Mouse
Species Reactivity: Human and Rat. Others not known.
Epitope: Carbohydrate domain
Immunogen: Microsomal fraction of human renal cortical tissue homogenate
Molecular Weight: ∽200kDa
Positive Control: Normal kidney or renal cell CA
Cellular Localization: Membrane and cytoplasmic
- Immunohistochemistry (Formalin/paraffin)
- Western Blotting (Reduced and nonreduced)
|Renal Cell Carcinoma Marker (gp200) Ab-1|
|Microsomal fraction of human renal cortical tissue homogenate|
|Immunohistochemistry (Paraffin), Western Blot|
|Cancer and Tumor Biology|
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.Ok